Green Tea Polyphenols Cause Apoptosis and Autophagy in HPV-16 Subgene-Immortalized Human Cervical Epithelial Cells via the Activation of the Nrf2 Pathway

References

• Tornesello ML, Faraonio R, Buonaguro L, Annunziata C, Starita N, Cerasuolo A, Pezzuto F, Tornesello AL, Buonaguro FM. The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer. Front Oncol. 2020;10:150. doi:10.3389/fonc.2020.00150
   PubMed Web of Science ®Google Scholar
• Xie L, Li J, Zhang Y, Liu B, Peng X, Lin Y, Xu W, Hu L. Inhibitors of differentiation-1 promotes nitrosopyrrolidine-induced transformation of HPV 16-immortalized cervical epithelial cell. Cancer Sci. 2014;105(5):506–11. doi:10.1111/cas.12398
   PubMed Web of Science ®Google Scholar
• Tsai HY, Ho CT, Chen YK. Biological actions and molecular effects of resveratrol, pterostilbene, and 3’-hydroxypterostilbene. J Food Drug Anal. 2017;25(1):134–47. doi:10.1016/j.jfda.2016.07.004
   PubMed Web of Science ®Google Scholar
• Pandey P, Khan F, Maurya P. Targeting Jab1 using hesperidin (dietary phytocompound) for inducing apoptosis in HeLa cervical cancer cells. J Food Biochem. 2021;45(7):e13800. doi:10.1111/jfbc.13800
   PubMed Web of Science ®Google Scholar
• Pandey P, Khan F, Alzahrani FA, Qari HA, Oves M. A novel approach to unraveling the apoptotic potential of rutin (bioflavonoid) via targeting Jab1 in cervical cancer cells. Molecules. 2021;26(18):5529. doi:10.3390/molecules26185529
   PubMed Web of Science ®Google Scholar
• Niedzwiecki A, Roomi M, Kalinovsky T, Rath M. Anticancer efficacy of polyphenols and their combinations. Nutrients. 2016;8(9):552. doi:10.3390/nu8090552
   PubMed Web of Science ®Google Scholar
• Singh M, Singh R, Bhui K, Tyagi S, Mahmood Z, Shukla Y. Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappaB and Akt activation in human cervical cancer cells. Oncol Res. 2011;19(6):245–57. doi:10.3727/096504011x13021877989711
   PubMed Web of Science ®Google Scholar
• Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.
   PubMed Web of Science ®Google Scholar
• Negri A, Naponelli V, Rizzi F, Bettuzzi S. Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer. Nutrients. 2018;10(12):1936. doi:10.3390/nu10121936
   PubMed Web of Science ®Google Scholar
• Xie L, Cai S, Zhao T, Li M, Tian Y. Green tea derivative (−)-epigallocatechin-3-gallate (EGCG) confers protection against ionizing radiation-induced intestinal epithelial cell death both in vitro and in vivo. Free Radic Biol Med. 2020;161:175–86. doi:10.1016/j.freeradbiomed.2020.10.012
   PubMed Web of Science ®Google Scholar
• Taguchi K, Yamamoto M. The KEAP1–NRF2 system in cancer. Front Oncol. 2017;7:85. 103389/fonc.2017.00085. doi:10.3389/fonc.2017.00085
   PubMed Web of Science ®Google Scholar
• Sanchez-Martin P, Saito T, Komatsu M. p62/SQSTM1: ‘Jack of all trades’ in health and cancer. Febs J. 2019;286(1):8–23. doi:10.1111/febs.14712
   PubMed Web of Science ®Google Scholar
• Gilson R, Nugent D, Werner RN, Ballesteros J, Ross J. 2019 IUSTI‐Europe guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2020;34(8):1644–53. doi:10.1111/jdv.16522
   PubMed Web of Science ®Google Scholar
• Sun Y, Li X, Song S, Wang Y, Gu H. Integrity of a HPV11 infection cell model and identification of (-)-Epigallocatechin-3-gallate as a potential HPV11 inhibitor. Oncotarget. 2016;7(24):37092–102. doi:10.18632/oncotarget.9249
   PubMedGoogle Scholar
• Zou C, Liu H, Feugang JM, Hao Z, Chow HS, Garcia F. Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer. 2010;20(4):617–24. doi:10.1111/IGC.0b013e3181c7ca5c
   PubMed Web of Science ®Google Scholar
• Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A. 2001;98(6):3410–5. doi:10.1073/pnas.051618798
   PubMed Web of Science ®Google Scholar
• Vega MRojoDeL, Chapman E, Zhang DD. NRF2 and the hallmarks of cancer. Cancer Cell. 2018;34(1):21–43. doi:10.1016/j.ccell.2018.03.022
   PubMed Web of Science ®Google Scholar
• Cruz-Gregorio A, Aranda-Rivera AK, Pedraza-Chaverri J. Nuclear factor erythroid 2-related factor 2 in human papillomavirus-related cancers. Rev Med Virol. 2021:e2308. doi:10.1002/rmv.2308
   PubMed Web of Science ®Google Scholar
• DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475(7354):106–9. doi:10.1038/nature10189
   PubMed Web of Science ®Google Scholar
• Kang J, Nam LB, Yoo O, Keum Y. Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer. Biochem Pharmacol. 2020;177:114002. doi:10.1016/j.bcp.2020.114002
   PubMed Web of Science ®Google Scholar
• Eckhardt M, Zhang W, Gross AM, Von Dollen J, Johnson JR, Franks-Skiba KE, Swaney DL, Johnson TL, Jang GM, Shah PS, et al. Multiple routes to oncogenesis are promoted by the human papillomavirus–host protein network. Cancer Discov. 2018;8(11):1474–89. doi:10.1158/2159-8290.CD-17-1018
   PubMed Web of Science ®Google Scholar
• Mittal S, Banks L. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation, Mutation research. Mutat Res Rev Mutat Res. 2017;772:23–35. doi:10.1016/j.mrrev.2016.08.001
   PubMed Web of Science ®Google Scholar
• Mattoscio D, Medda A, Chiocca S. Human papilloma virus and autophagy. IJMS. 2018;19(6):1775. doi:10.3390/ijms19061775
   Web of Science ®Google Scholar
• Belleudi F, Nanni M, Raffa S, Torrisi MR. HPV16 E5 deregulates the autophagic process in human keratinocytes. Oncotarget. 2015;6(11):9370–86. doi:10.18632/oncotarget.3326
   PubMedGoogle Scholar
• Bartolini D, Dallaglio K, Torquato P, Piroddi M, Galli F. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma. Transl Res. 2018;193:54–71. doi:10.1016/j.trsl.2017.11.007
   PubMed Web of Science ®Google Scholar